Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estetrol (E4) for Hospitalized Moderate COVID-19
NCT04801836Phase 2Unknown
- Start
- Nov 2020
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of estetrol in coronavirus disease 2019 (COVID-19). Status: unknown.
02
Drugs
estetrol
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04801836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04801836.